The next events include the dysregulation of ETS transcription factor, loss of NKX3.1, mutations of SPOP, and TMPRSS2–ERG fusion at the prostatic intraepithelial neoplasia (PIN) stage. The gene discussed is TMPRSS2; the disease is prostate intraepithelial neoplasia.